New WHO Public Inspection Reports (WHOPIRs) published
M
Past News
Clarifications regarding carton-free supply of prequalified products packaged in bottles
M
PQTm acknowledges the advantages of carton-free supply of medicinal products that are presented in bottle packs and therefore support initiatives for carton free packaging being promoted by various
Clarifications regarding carton-free supply of prequalified products packaged in bottles
M
PQTm acknowledges the advantages of carton-free supply of medicinal products that are presented in bottle packs and therefore support initiatives for carton free packaging being promoted by various
Revised Appendix for Bioequivalence Trial Information (BTIF)
M
In September 2018, an appendix was added to the Bioe
First co-pack of mifepristone oral tablet and misoprostol for vaginal administration prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Levofloxacin 750mg tablets prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Guilin’s DHA/piperaquine 40mg/320mg and 20mg/160mg dispersible tablets prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Guilin’s DHA/piperaquine 40mg/320mg and 80mg/640mg tablets prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Dolutegravir/lamivudine/tenofovir tablets prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO launches first-ever insulin prequalification programme to expand access to life-saving treatment for diabetes
ID
IVD
M
V
VCP
The World Health Organization (WHO) today announced the start of a pilot programme to prequalify human insulin to increase treatment for diabetes in low- and middle-income countries.
WHO prequalifies Ebola vaccine, paving the way for its use in high-risk countries
ID
IVD
M
V
VCP
The World Health Organization (WHO) today prequalified an Ebola vaccine for the first time, a critical step that will help speed up its licensing, access and roll-out in countries most at risk of E
Nitrosamine contamination – Recent international alerts
M
The WHO Prequalification Team (PQT) is aware, and monitoring closely, announcements by major regulators regarding the presence of nitrosamine impurities in batches of sartan-related products,
WHO signs MoU with International Generic and Biosimilar Medicines Association to promote access
M
Full access to medicines is hampered by a variety o
Micro Labs’ 100mg dispersible levofloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Guidance on amendments has been revised
M
The guidance document on amendments to an Active Pharmaceutical Ingredient Master File (APIMF) submitted in support of a Prequalified Pharmaceutical Product (FPP) or Prequalified Active Pharmaceuti
Laurus’ dolutegravir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Oxytocin injections prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Product Recall - Moxifloxacin 100mg Dispersible Tablets (TB342): Batch BMC5801A
M
On 28 May 2019, Macleods Pharmaceutical Ltd.
Unique’s ciprofloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Mylan’s darunavir 600mg and 800mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Sun’s abacavir/lamivudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Krka’s darunavir 600mg tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Macleods’ streptomycin injection prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
First generic daclatasvir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Macleods’ amodiaquine/artesunate tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
MSN’s levofloxacin tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:
Micro Labs’ lamivudine/nevirapine/zidovudine tablet prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list: